Fundamentals and stats

An in-depth look to Acumen Pharmaceuticals, Inc. operating, investing, and financing activities

ABOS free cash flow for Q3 25 is -30.49 M USD. For 2024, ABOS free cash flow was -86.23 M USD and operating cash flow was -86.22 M USD.

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Q3 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: USD